Sun Pharma: How a small Kolkata trader became a global buyout artist

Sun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continues Shanghvi's proven strategy of acquiring companies to fuel growth and global expansion. His approach prioritizes strategic advantage and turnaround potential, as seen in past landmark deals like Ranbaxy and Taro.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fX9BkGL
via IFTTT